Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Monocentric, exploratory study comparing 68Ga-RM2 PET / CT to 68Ga-PSMA-617 PET / CT in prostate cancer patients with different metastatic risks, candidates for total prostatectomy (Etude monocentrique, exploratoire, comparant la TEP/TDM au 68Ga-RM2 à la TEP/TDM au 68Ga-PSMA-617 chez des patients atteints de cancers de la prostate de différents risques métastatiques, candidats à une prostatectomie totale}

X
Trial Profile

Monocentric, exploratory study comparing 68Ga-RM2 PET / CT to 68Ga-PSMA-617 PET / CT in prostate cancer patients with different metastatic risks, candidates for total prostatectomy (Etude monocentrique, exploratoire, comparant la TEP/TDM au 68Ga-RM2 à la TEP/TDM au 68Ga-PSMA-617 chez des patients atteints de cancers de la prostate de différents risques métastatiques, candidats à une prostatectomie totale}

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 04 Nov 2021

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs 68-Ga-PSMA-617 (Primary) ; Gallium 68 RM2 (Primary)
  • Indications Prostate cancer
  • Focus Diagnostic use
  • Acronyms UROPET
  • Most Recent Events

    • 12 Jun 2020 This trial is completed (Global End Date: 11 Dec 2019), according to European Clinical Trials Database record.
    • 09 Jun 2020 Status changed from recruiting to completed.
    • 18 Dec 2019 Planned End Date changed from 31 Dec 2019 to 25 Jun 2020.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top